Amgen: Clinical Trials & Research Profile
Biopharma Industry (Thousand Oaks, CA) · Primary Focus: Immunology, Rheumatology, and Dermatology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Thousand Oaks, CA) |
| Primary Therapeutic Area | Immunology, Rheumatology, and Dermatology |
| Active Phase II & III Studies | 66 active (28 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 153 (113 with California sites) |
| Completed vs Early-Stopped Studies | 56 completed / 31 stopped (20.3% stop rate) |
| Median Closed Enrollment | 214 participants |
| FDA Drugs@FDA Original Approvals | 44 all-time (17 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 95.7% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Amgen across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk